Ray Kruse Iles is a biomedical scientist who was head of the Williamson Laboratory for Molecular Oncology at St Bartholomew's Hospital in London.[1]
Career
Iles has a particular interest in the interface between rational processing, emotional motivation and endocrinology.[2]
He co-founded the ELK-Health Foundation, with psychotherapist Tadhg Ó Séaghdha, in 2004. The ELK-Foundation Health (named after Iles's father, Eric Leonard Kruse) is now the National Institutes for Stress, Anxiety and Depression (NISAD), centred in Lund, Sweden. It still uses the ELK-Health name in its programmes and clinics, which support people needing to change habits that harm their physical and emotional health.
Iles's interest in women's and reproduction health led him, in 2011, to become the founding director of the biomarker diagnostic company MAPSciences.[3]
His academic career, after leaving St Bartholomew's, included being Professor of Biomedical Science at Middlesex University heading a Biomedical Science Research Facility, which incorporated molecular pathology, bio-modelling/bioinformatics and environmental health,[14][15] and then Anglia Ruskin University.[16]
Formerly a regular contributor to Kumar and Clark's Clinical Medicine,[17] Iles left academia to concentrate on the two organisations that he co-founded, NISAD and MapSciences.
In 2012, with Suzanne Docherty, he published the textbook Biomedical Science: Essential Laboratory Medicine.[5]
NISAD has supported several research projects of Iles and his students in bioanalysis,[18] cancer research,[19][20] fertility[21] and prenatal care and child development.[22][23][24]
In 2019 Iles became founding dean at Abu Dhabi University’s College of Health Sciences. In July 2020 he became visiting professor at the Laboratory of Viral Zoonotics, University of Cambridge.[25]
^US RE47260, Zhao, Qianglin Quintin & Chen, Huaimo, "System and method for point to multipoint inter-domain MPLS traffic engineering path calculation", issued February 26, 2019
^Trivedi, Drupad K.; Iles, Ray K. (November 2014). "Do not just do it, do it right: urinary metabolomics -establishing clinically relevant baselines: Choosing correct tools for shotgun urinary metabolomics". Biomedical Chromatography. 28 (11): 1491–1501. doi:10.1002/bmc.3219. PMID24788800.
^Iles, R.K. (January 2007). "Ectopic hCGβ expression by epithelial cancer: Malignant behaviour, metastasis and inhibition of tumor cell apoptosis". Molecular and Cellular Endocrinology. 260–262: 264–270. doi:10.1016/j.mce.2006.02.019. ISSN0303-7207. PMID17069968. S2CID21216536.
^Butler, Stephen A.; Staite, Edyta M.; Iles, Ray K. (2003-01-01). "Reduction of Bladder Cancer Cell Growth in Response to hCGβ CTP37 Vaccinated Mouse Serum". Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14 (2): 93–100. doi:10.3727/000000003108748649. ISSN0965-0407. PMID14649543.
^Butler, Stephen A.; Luttoo, Jameel; Freire, Maísa O. T.; Abban, Thomas K.; Borrelli, Paola T. A.; Iles, Ray K. (September 2013). "Human Chorionic Gonadotropin (hCG) in the Secretome of Cultured Embryos: Hyperglycosylated hCG and hCG-Free Beta Subunit Are Potential Markers for Infertility Management and Treatment". Reproductive Sciences. 20 (9): 1038–1045. doi:10.1177/1933719112472739. ISSN1933-7191. PMID23439616. S2CID25291112.
^Trivedi, Drupad K.; Iles, Ray K. (August 2015). "Shotgun metabolomic profiles in maternal urine identify potential mass spectral markers of abnormal fetal biochemistry - dihydrouracil and progesterone in the metabolism of Down syndrome: Maternal urinary metabolomics markers of Down syndrome". Biomedical Chromatography. 29 (8): 1173–1183. doi:10.1002/bmc.3404. PMID25545476.
^Butler, Stephen A.; Abban, Thomas K.A.; Borrelli, Paola T.A.; Luttoo, Jameel M.; Kemp, Bryn; Iles, Ray K. (September 2013). "Single point biochemical measurement algorithm for early diagnosis of ectopic pregnancy". Clinical Biochemistry. 46 (13–14): 1257–1263. doi:10.1016/j.clinbiochem.2013.06.019. PMID23830901.
^ ab"Ray Iles". ResearchGate. Retrieved 13 February 2023.